<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02938858</url>
  </required_header>
  <id_info>
    <org_study_id>French registry APL</org_study_id>
    <nct_id>NCT02938858</nct_id>
  </id_info>
  <brief_title>French Registry of First-line Treatment of Acute Promyelocytic Leukemia</brief_title>
  <official_title>The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Francophone des Myelodysplasies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>TEVA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Francophone des Myelodysplasies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The registry aims to compare the two first-line available treatment approaches in
      non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO - in
      terms of practitioner's choice between the two options, clinical effectiveness and
      cost-effectiveness, long-term outcome, and short- and long-term toxic effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Collection of epidemiological data on non-high-risk APL patients aged ≤ 70 years: age
           and sex distribution, medical history, prognostic factors (time to treatment start,
           severity of coagulopathy at presentation, Performance status…).

        -  Documentation of clinical and biologic effectiveness of the two first-line treatment
           approaches available for non-high-risk APL patients.

        -  Documentation of Minimal Residual Disease (MRD).

        -  Correlation of clinical outcomes with the chosen therapy.

        -  Validation of published prognostic factors and identification of new prognostic factors
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Event-free survival</measure>
    <time_frame>From date of induction until the date of first documented event, assessed up to 60 months</time_frame>
    <description>events are: no achievement of haematological complete remission after induction therapy; no achievement of molecular remission after the consolidation courses; relapse; death including early death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of hematological complete remission</measure>
    <time_frame>up to 30 days</time_frame>
    <description>from date of inclusion until end of induction therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of overall survival</measure>
    <time_frame>at 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Acute Promyelocytic Leukemia</condition>
  <arm_group>
    <arm_group_label>ATRA-chimio</arm_group_label>
    <description>according to usual practice center</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ATRA-ATO</arm_group_label>
    <description>according to usual practice center</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        French patients with newly-diagnosed de novo or therapy-related non-high-risk APL (White
        Blood Count &lt; 10000/μl) aged ≤ 70 years.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly-diagnosed APL (either de novo or therapy-related) based on cytologic criteria
             and confirmed by the presence of the t(15;17) translocation and/or by the detection of
             the fusion transcript PML/RARα.

          -  Non-high-risk APL (White Blood Count &lt; 10000/μl at presentation)

          -  Age ≤ 70 years

        Exclusion Criteria:

          -  Relapsed APL

          -  Newly-diagnosed High-risk APL (White Blood Count &gt; 10000/μl at presentation)

          -  Age &gt; 70 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre FENAUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>French APL Cooperative Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre FENAUX, MD</last_name>
    <phone>+33 1 71 20 70 18</phone>
    <email>pierre.fenaux@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ramy RAHME, MD</last_name>
    <phone>+ 33 1 71 20 70 22</phone>
    <email>ramy.rahme@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier d'Aix en Provence</name>
      <address>
        <city>Aix en Provence</city>
        <zip>13616</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie CAILLERES, MD</last_name>
      <phone>04 42 33 90 94</phone>
      <email>scailleres@ch-aix.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier SUD</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine LEBON, MD</last_name>
      <phone>03 22 45 59 14</phone>
      <email>lebon.delphine@chu-amiens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier V. Dupouy</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmad ALJIJAKLI, MD</last_name>
      <phone>01 34 23 20 16</phone>
      <email>ahmad.aljijakli@ch-argenteuil.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice LAROSA, MD</last_name>
      <phone>03 81 66 82 32</phone>
      <email>flarosa@chu-besancon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux Pellegrin enfant</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte JUBERT, MD</last_name>
      <phone>05 57 82 04 35</phone>
      <email>charlotte.jubert@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Brest - Pédiatrie Spécialisée</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liana CARAUSU, MD</last_name>
      <phone>02 98 22 37 70</phone>
      <email>liana.carausu@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria CACHEUX, MD</last_name>
      <phone>04 73 75 00 65</phone>
      <email>vcacheux@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence BECKERICH, MD</last_name>
      <phone>01 49 81 20 57</phone>
      <email>florence.beckerich@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin CARRE, MD</last_name>
      <phone>04 76 76 56 95</phone>
      <email>mcarre1@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Andre Mignot</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Laure TAKSIN, MD</last_name>
      <phone>01 39 63 91 33</phone>
      <email>altaksin@ch-versailles.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Dr Schaffner</name>
      <address>
        <city>Lens</city>
        <zip>62307</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte DUPRIEZ, MD</last_name>
      <phone>03 21 69 13 67</phone>
      <email>bdupriez@ch-lens.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chru - Hopital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline BERTHON, MD</last_name>
      <phone>03 20 44 57 13</phone>
      <email>celine.berthon@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital universitaire Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Pierre GOURIN, MD</last_name>
      <phone>05 55 05 66 51</phone>
      <email>marie-pierre.gourin@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13273</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert VEY, MD</last_name>
      <phone>04 91 22 36 68</phone>
      <email>veyn@ipc.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérard MICHEL, MD</last_name>
      <phone>04 91 38 69 63</phone>
      <email>gerard.michel@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHR Metz-Thionville - Hôpital de Marcy</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Houria DEBARRI, MD</last_name>
      <phone>03 87 55 33 04</phone>
      <email>h.debarri@chr-metz-thionville.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Saint Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34095</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yosr HICHERI, MD</last_name>
      <phone>04 67 33 83 62</phone>
      <email>y-hicheri@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre PETERLIN, MD</last_name>
      <phone>02 40 08 32 71</phone>
      <email>pierre.peterlin@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Source</name>
      <address>
        <city>Orléans</city>
        <zip>45100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana CARP, MD</last_name>
      <phone>02 38 61 34 23</phone>
      <email>diana.carp@chr-orleans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital TROUSSEAU</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean DONADIEU, MD</last_name>
      <phone>01 44 73 53 14</phone>
      <email>jean.donadieu@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ambroise MARCAIS, MD</last_name>
      <phone>01 44 49 46 83</phone>
      <email>ambroise.marcais@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit BRETHON, MD</last_name>
      <phone>01 71 28 25 22</phone>
      <email>benoit.brethon@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Sud - service Hémato-oncologie Pédiatrique</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie GANDEMER, MD</last_name>
      <email>virginie.gandemer@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital V. Provo</name>
      <address>
        <city>Roubaix</city>
        <zip>59056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle DERVITE, MD</last_name>
      <phone>03 20 99 32 70</phone>
      <email>isabelle.dervite@ch-roubaix.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aspasia STAMATOULLAS, MD</last_name>
      <phone>02 32 08 22 88</phone>
      <email>aspasia.stamatoullas@chb.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de Cancerologie de La Loire</name>
      <address>
        <city>Saint Priest-en-jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle TAVERNIER, MD</last_name>
      <phone>04 77 91 70 76</phone>
      <email>emmanuelle.tavernier@icloire.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IUCT Oncopole</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian RECHER, MD</last_name>
      <phone>05 61 77 20 78</phone>
      <email>recher.chistian@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2016</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Promyelocytic, Acute</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

